BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 26497782)

  • 1. Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPARγ and 5-HT1A receptors.
    Hind WH; England TJ; O'Sullivan SE
    Br J Pharmacol; 2016 Mar; 173(5):815-25. PubMed ID: 26497782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocannabinoids modulate human blood-brain barrier permeability in vitro.
    Hind WH; Tufarelli C; Neophytou M; Anderson SI; England TJ; O'Sullivan SE
    Br J Pharmacol; 2015 Jun; 172(12):3015-27. PubMed ID: 25651941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligustilide Ameliorates the Permeability of the Blood-Brain Barrier Model In Vitro During Oxygen-Glucose Deprivation Injury Through HIF/VEGF Pathway.
    Wu S; Wang N; Li J; Wang G; Seto SW; Chang D; Liang H
    J Cardiovasc Pharmacol; 2019 May; 73(5):316-325. PubMed ID: 30855407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.
    Espejo-Porras F; Fernández-Ruiz J; Pertwee RG; Mechoulam R; García C
    Neuropharmacology; 2013 Dec; 75():155-63. PubMed ID: 23924692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective Effects of Cannabidivarin and Cannabigerol on Cells of the Blood-Brain Barrier Under Ischemic Conditions.
    Stone NL; England TJ; O'Sullivan SE
    Cannabis Cannabinoid Res; 2021 Aug; 6(4):315-326. PubMed ID: 33998890
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertonic saline alleviates experimentally induced cerebral oedema through suppression of vascular endothelial growth factor and its receptor VEGFR2 expression in astrocytes.
    Huang L; Cao W; Deng Y; Zhu G; Han Y; Zeng H
    BMC Neurosci; 2016 Oct; 17(1):64. PubMed ID: 27733124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome-proliferator-activated receptor-alpha activation protects brain capillary endothelial cells from oxygen-glucose deprivation-induced hyperpermeability in the blood-brain barrier.
    Mysiorek C; Culot M; Dehouck L; Derudas B; Staels B; Bordet R; Cecchelli R; Fenart L; Berezowski V
    Curr Neurovasc Res; 2009 Aug; 6(3):181-93. PubMed ID: 19534718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection Following Concussion: The Potential Role for Cannabidiol.
    Singh J; Neary JP
    Can J Neurol Sci; 2020 May; 47(3):289-300. PubMed ID: 32029015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential contribution of CB1, CB2, 5-HT1A, and PPAR-γ receptors to cannabidiol effects on ischemia-induced emotional and cognitive impairments.
    Mori MA; Meyer E; da Silva FF; Milani H; Guimarães FS; Oliveira RMW
    Eur J Neurosci; 2021 Mar; 53(6):1738-1751. PubMed ID: 33522084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors.
    Pazos MR; Mohammed N; Lafuente H; Santos M; Martínez-Pinilla E; Moreno E; Valdizan E; Romero J; Pazos A; Franco R; Hillard CJ; Alvarez FJ; Martínez-Orgado J
    Neuropharmacology; 2013 Aug; 71():282-91. PubMed ID: 23587650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective Effects of Cannabidiol but Not Δ
    Landucci E; Mazzantini C; Lana D; Davolio PL; Giovannini MG; Pellegrini-Giampietro DE
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apelin-13 Protects against Ischemic Blood-Brain Barrier Damage through the Effects of Aquaporin-4.
    Chu H; Yang X; Huang C; Gao Z; Tang Y; Dong Q
    Cerebrovasc Dis; 2017; 44(1-2):10-25. PubMed ID: 28402976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small GTPase RhoA and its effector rho kinase mediate oxygen glucose deprivation-evoked in vitro cerebral barrier dysfunction.
    Allen C; Srivastava K; Bayraktutan U
    Stroke; 2010 Sep; 41(9):2056-63. PubMed ID: 20651275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors.
    Castillo A; Tolón MR; Fernández-Ruiz J; Romero J; Martinez-Orgado J
    Neurobiol Dis; 2010 Feb; 37(2):434-40. PubMed ID: 19900555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of urokinase activity during experimental ischaemia protects the cerebral barrier from damage through regulation of matrix metalloproteinase-2 and NAD(P)H oxidase.
    Rakkar K; Srivastava K; Bayraktutan U
    Eur J Neurosci; 2014 Jun; 39(12):2119-28. PubMed ID: 24649947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. bFGF Protects Against Oxygen Glucose Deprivation/Reoxygenation-Induced Endothelial Monolayer Permeability via S1PR1-Dependent Mechanisms.
    Lin L; Wang Q; Qian K; Cao Z; Xiao J; Wang X; Li X; Yu Z
    Mol Neurobiol; 2018 Apr; 55(4):3131-3142. PubMed ID: 28466272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvascular endothelial cells-derived microvesicles imply in ischemic stroke by modulating astrocyte and blood brain barrier function and cerebral blood flow.
    Pan Q; He C; Liu H; Liao X; Dai B; Chen Y; Yang Y; Zhao B; Bihl J; Ma X
    Mol Brain; 2016 Jun; 9(1):63. PubMed ID: 27267759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC3 inhibition prevents oxygen glucose deprivation/reoxygenation-induced transendothelial permeability by elevating PPARγ activity in vitro.
    Zhao Q; Yu Z; Zhang F; Huang L; Xing C; Liu N; Xu Y; Wang X
    J Neurochem; 2019 Apr; 149(2):298-310. PubMed ID: 30347434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-allose protects the blood brain barrier through PPARγ-mediated anti-inflammatory pathway in the mice model of ischemia reperfusion injury.
    Huang T; Gao D; Hei Y; Zhang X; Chen X; Fei Z
    Brain Res; 2016 Jul; 1642():478-486. PubMed ID: 27103568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A time-dependent contribution of hippocampal CB
    Raymundi AM; da Silva TR; Zampronio AR; Guimarães FS; Bertoglio LJ; Stern CAJ
    Br J Pharmacol; 2020 Feb; 177(4):945-957. PubMed ID: 31648363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.